Loading...
Loading...
Vanda Pharmaceuticals
VNDA shares jumped 16.65% to $12.96 in pre-market trading on Q3 results. Vanda Pharma posted a quarterly loss of $0.64 per share on revenue of $10.90 million.
Prosensa Holding N.V.
RNA shares jumped 12.07% to $13.46 in pre-market trading on the FDA requirement of additional data from Sarepta on Eteplirsen.
Novavax
NVAX shares rose 9.16% to $5.60 in pre-market trading after the company announced Ebola vaccine development program at the 8th Vaccine And ISV Conference in Philadelphia.
Micron Technology
MU gained 2.64% to $31.88 in pre-market trading after the company announced a new$1 billion stock repurchase authorization.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in